Wenn COVID nicht aufhört: Post-COVID-Verläufe mit Fatigue und Belastungsintoleranz

Herbert Renz-Polster; Carmen Scheibenbogen

doi:10.1055/a-1849-8953

DMW - Deutsche Medizinische Wochenschrift, Table of Contents

Dtsch Med Wochenschr 2022; 147(20): 1320-1330
DOI: 10.1055/a-1849-8953

Dossier

Wenn COVID nicht aufhört: Post-COVID-Verläufe mit Fatigue und Belastungsintoleranz

When COVID does not heal: post-COVID courses with fatigue and exercise intolerance

Authors

Herbert Renz-Polster
Carmen Scheibenbogen

Abstract

Hinter „Post-COVID“ verbergen sich pathobiologisch unterschiedliche Entitäten, von Schädigungen bestimmter Organe bis hin zu neu auftretenden Autoimmun-Erkrankungen. In diesem Beitrag wird es vor allem um die Langzeitverläufe mit den Leitsymptomen Fatigue und Belastungsintoleranz gehen. Sie sind auch von anderen Infektionskrankheiten bekannt und umfassen als schwerwiegendste Entität die Systemerkrankung Myalgische Enzephalomyelitis/Chronisches Fatigue-Syndrom.

Abstract

Post-COVID-Syndrome consists of several pathobiologically different entities, ranging from damage to specific organs to new onset autoimmune diseases. This article focuses on post-COVID courses with the leading symptoms of fatigue and exercise intolerance. This category is also known from other infectious diseases and includes myalgic encephalomyelitis/chronic fatigue syndrome.

Schlüsselwörter

Post-COVID-Syndrom - Long-COVID - chronisches Fatigue-Syndrom - posturales Tachykardiesyndrom - Belastungsintoleranz

Key words

post-COVID syndrome - long-COVID - chronic fatigue syndrome - postural tachycardia syndrome - exercise intolerance

Full Text

References

Literatur
1 AWMF. S1-Leitlinie Long/Post-COVID. AWMF-Register-Nr. 020-027; 17.08.2022. Im Internet (Stand: 19.08.2022): https://www.awmf.org/leitlinien/detail/ll/020-027.html
2 Yong SJ, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol 2022; 32: e2315
3 Kedor C, Freitag H, Meyer-Arndt L. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun 2022; 13 (01) 5104
4 Couzin-Frankel J, Vogel G. In rare cases, coronavirus vaccines may cause Long Covid-like symptoms. Im Internet (Stand: 18.08.2022): https://www.science.org/content/article/rare-cases-coronavirus-vaccines-may-cause-long-covid-symptoms
5 Davis HE, Assaf GS, McCorkell L. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38: 101019
6 Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol 2021; 12: 698169
7 Krishna BA, Lim EY, Mactavous L. et al. Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID. EBioMedicine 2022; 81: 104129
8 Sudre CH, Murray B, Varsavsky T. et al. Attributes and predictors of long COVID. Nat Med 2021; 27: 626-631
9 Chen C, Haupert SR, Zimmermann L. et al. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis 2022; 136
10 Han Q, Zheng B, Daines L. et al. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens 2022; 11: 269
11 Buchberger B, Zwierlein R, Rohde V. Post-Corona-Fatigue – das bekannte Bild in neuem Gewand?. Onkologe (Berl.) 2022; 28: 340-346
12 Cerqueira É, Marinho DA, Neiva HP. et al. Inflammatory Effects of High and Moderate Intensity Exercise – A Systematic Review. Front Physiol 2020; 10: 1550
13 Renz-Polster H, Tremblay ME, Bienzle D. et al. The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure. Front Cell Neurosci 2022; 16: 888232
14 Wirth K, Scheibenbogen C. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against β2-adrenergic receptors. Autoimmun Rev 2020; 19: 102527
15 Chadda KR, Blakey EE, Huang CLH. et al. Long COVID-19 and Postural Orthostatic Tachycardia Syndrome – Is Dysautonomia to Be Blamed?. Front Cardiovasc Med 2022; 9: 860198
16 Klingenheben T. Autonome Dysfunktion und orthostatische Intoleranz. Internist 2002; 43: 1055-1064
17 Wise S, Ross A, Brown A. et al. An assessment of fatigue in patients with postural orthostatic tachycardia syndrome. J Health Psychol 2017; 22: 733-742
18 Vernino S, Bourne KM, Stiles LE. et al. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting – Part 1. J Auton Nerv Syst 2021; 235: 102828
19 Joseph A, Wanono R, Flamant M. et al. Orthostatic hypotension: A review. Nephrol Ther 2017; 13 (Suppl. 01) S55-S67
20 Choutka J, Jansari V, Hornig M. et al. Unexplained post-acute infection syndromes. Nat Med 2022; 28: 911-923
21 Lam MHB, Wing YK, Yu MWM. et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med 2009; 169: 2142-2147
22 Renz-Polster H, Scheibenbogen C. Post-COVID-Syndrom mit Fatigue und Belastungsintoleranz: Myalgische Enzephalomyelitis bzw. Chronisches Fatigue-Syndrom. Inn Med (Heidelb) 2022; 63: 830-839
23 Jason LA, Mirin AA. Updating the National Academy of Medicine ME/CFS prevalence and economic impact figures to account for population growth and inflation. Fatigue Biomed Health Behav 2021; 9: 9-13
24 Tokumasu K, Honda H, Sunada N. et al. Clinical Characteristics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed in Patients with Long COVID. Medicina (Kaunas) 2022; 58: 850
25 Sukocheva OA, Maksoud R, Beeraka NM. et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J Adv Res 2021;
26 Pendergrast T, Brown A, Sunnquist M. et al. Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn 2016; 12: 292-307
27 Nacul L, O’Boyle S, Palla L. et al. How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS. Front Neurol 2020; 11: 826
28 Carruthers BM, Jain AK, De Meirleir KL. et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Chronic Fatigue Syndr 2003; 11: 7-115
29 van Campen CLMC, Verheugt FWA, Rowe PC. et al. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography. Clin Neurophysiol Pract 2020; 5: 50-58
30 Melamed KH, Santos M, Oliveira RKF. et al. Unexplained exertional intolerance associated with impaired systemic oxygen extraction. Eur J Appl Physiol 2019; 119: 2375-2389
31 Joseph P, Arevalo C, Oliveira RKF. et al. Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Chest 2021; 160: 642-651
32 Singh I, Joseph P, Heerdt PM. et al. Persistent Exertional Intolerance after COVID-19: Insights from Invasive Cardiopulmonary Exercise Testing. Chest 2021; 161: 54-63
33 van Campen CLMC, Rowe PC, Visser FC. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Medicina (Kaunas) 2022; 58: 28
34 Wallukat G, Hohberger B, Wenzel K. et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 2021; 4: 100100
35 Loebel M, Grabowski P, Heidecke H. et al. Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav Immun 2016; 52: 32-39